156 related articles for article (PubMed ID: 15264180)
1. Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation.
Uesugi N; Sakata N; Nangaku M; Abe M; Horiuchi S; Hisano S; Iwasaki H
Am J Kidney Dis; 2004 Aug; 44(2):224-38. PubMed ID: 15264180
[TBL] [Abstract][Full Text] [Related]
2. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease.
Tanji N; Markowitz GS; Fu C; Kislinger T; Taguchi A; Pischetsrieder M; Stern D; Schmidt AM; D'Agati VD
J Am Soc Nephrol; 2000 Sep; 11(9):1656-1666. PubMed ID: 10966490
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions.
Suzuki D; Miyata T; Saotome N; Horie K; Inagi R; Yasuda Y; Uchida K; Izuhara Y; Yagame M; Sakai H; Kurokawa K
J Am Soc Nephrol; 1999 Apr; 10(4):822-32. PubMed ID: 10203367
[TBL] [Abstract][Full Text] [Related]
4. Glycoxidation-modified macrophages and lipid peroxidation products are associated with the progression of human diabetic nephropathy.
Uesugi N; Sakata N; Horiuchi S; Nagai R; Takeya M; Meng J; Saito T; Takebayashi S
Am J Kidney Dis; 2001 Nov; 38(5):1016-25. PubMed ID: 11684555
[TBL] [Abstract][Full Text] [Related]
5. Carboxymethyllysine in dermal tissues of diabetic and nondiabetic patients with chronic renal failure: relevance to glycoxidation damage.
Meng J; Sakata N; Imanaga Y; Takebayashi S; Nagai R; Horiuchi S
Nephron; 2001 May; 88(1):30-5. PubMed ID: 11340347
[TBL] [Abstract][Full Text] [Related]
6. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.
Meng J; Sakata N; Takebayashi S; Asano T; Futata T; Nagai R; Ikeda K; Horiuchi S; Myint T; Taniguchi N
Atherosclerosis; 1998 Feb; 136(2):355-65. PubMed ID: 9543107
[TBL] [Abstract][Full Text] [Related]
7. Activation of tubular epithelial cells in diabetic nephropathy.
Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
9. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease.
Sakata N; Imanaga Y; Meng J; Tachikawa Y; Takebayashi S; Nagai R; Horiuchi S
Atherosclerosis; 1999 Jan; 142(1):67-77. PubMed ID: 9920507
[TBL] [Abstract][Full Text] [Related]
10. N(epsilon)-(carboxymethyl)lysine in atherosclerotic vascular lesions as a marker for local oxidative stress.
Nerlich AG; Schleicher ED
Atherosclerosis; 1999 May; 144(1):41-7. PubMed ID: 10381276
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy.
Nishino T; Horii Y; Shiiki H; Yamamoto H; Makita Z; Bucala R; Dohi K
Hum Pathol; 1995 Mar; 26(3):308-13. PubMed ID: 7890283
[TBL] [Abstract][Full Text] [Related]
12. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
13. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.
Koschinsky T; He CJ; Mitsuhashi T; Bucala R; Liu C; Buenting C; Heitmann K; Vlassara H
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6474-9. PubMed ID: 9177242
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy.
Makino H; Shikata K; Hironaka K; Kushiro M; Yamasaki Y; Sugimoto H; Ota Z; Araki N; Horiuchi S
Kidney Int; 1995 Aug; 48(2):517-26. PubMed ID: 7564121
[TBL] [Abstract][Full Text] [Related]
15. Carbonyl stress in the pathogenesis of diabetic nephropathy.
Suzuki D; Miyata T
Intern Med; 1999 Apr; 38(4):309-14. PubMed ID: 10361902
[TBL] [Abstract][Full Text] [Related]
16. Increased carbonyl modification by lipids and carbohydrates in diabetic nephropathy.
Miyata T; Sugiyama S; Suzuki D; Inagi R; Kurokawa K
Kidney Int Suppl; 1999 Jul; 71():S54-6. PubMed ID: 10412738
[TBL] [Abstract][Full Text] [Related]
17. Glomerulosclerosis, hemochromatosis, and diabetes mellitus.
Kreines K; Kim OJ; Knowles HC
Am J Clin Pathol; 1970 Jul; 54(1):47-52. PubMed ID: 5504618
[No Abstract] [Full Text] [Related]
18. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
Nangaku M; Miyata T; Sada T; Mizuno M; Inagi R; Ueda Y; Ishikawa N; Yuzawa H; Koike H; van Ypersele de Strihou C; Kurokawa K
J Am Soc Nephrol; 2003 May; 14(5):1212-22. PubMed ID: 12707391
[TBL] [Abstract][Full Text] [Related]
19. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
20. Histological localization of advanced glycosylation end products in the progression of diabetic nephropathy.
Imai N; Nishi S; Suzuki Y; Karasawa R; Ueno M; Shimada H; Kawashima S; Nakamaru T; Miyakawa Y; Araki N; Horiuchi S; Gejyo F; Arakawa M
Nephron; 1997; 76(2):153-60. PubMed ID: 9200406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
